Literature DB >> 16135770

Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.

A M Blouin1, T C Thannickal, P F Worley, J M Baraban, I M Reti, J M Siegel.   

Abstract

OBJECTIVE: To investigate whether neuronal activity-regulated pentraxin (Narp) colocalizes with hypocretin (Hcrt or orexin) in the normal human brain and to determine if Narp staining is lost in the narcoleptic human brain.
BACKGROUND: Human narcolepsy is characterized by a loss of the peptide hypocretin in the hypothalamus. This loss could result from the degeneration of neurons containing hypocretin or from a more specific loss of the ability of these neurons to synthesize Hcrt. Narp has been found to colocalize with hypocretin in the rat hypothalamus.
METHODS: We investigated the distribution of Narp in three normal and four narcoleptic human postmortem brains using immunohistochemistry with an antibody to Narp. Colocalization studies of Narp and hypocretin were also performed in two normal brains using immunohistochemistry with an antibody to Narp and an antibody to hypocretin.
RESULTS: We found that Narp colocalizes with hypocretin in the lateral hypothalamic area (LHA), the dorsomedial hypothalamus (DMH), the dorsal hypothalamic area (DHA), and the posterior hypothalamic area (PHA) of the normal human. The number of Narp-positive neurons was reduced by 89% in these areas of the narcoleptic hypothalamus. In contrast, Narp staining in the paraventricular (Pa) and supraoptic nuclei (SO) of the human hypothalamus did not differ between normal and narcoleptic brains.
CONCLUSIONS: This finding supports the hypothesis that narcolepsy results from the specific loss of hypocretin neurons. Loss of hypothalamic Narp may contribute to the symptoms of narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135770      PMCID: PMC8765220          DOI: 10.1212/01.wnl.0000175219.01544.c8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

2.  Orexin (hypocretin) neurons contain dynorphin.

Authors:  T C Chou; C E Lee; J Lu; J K Elmquist; J Hara; J T Willie; C T Beuckmann; R M Chemelli; T Sakurai; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

3.  Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.

Authors:  Thomas C Thannickal; Jerome M Siegel; Robert Nienhuis; Robert Y Moore
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

4.  Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons.

Authors:  Irving M Reti; Radhika Reddy; Paul F Worley; Jay M Baraban
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

5.  Prominent Narp expression in projection pathways and terminal fields.

Authors:  Irving M Reti; Radhika Reddy; Paul F Worley; Jay M Baraban
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

6.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

  6 in total
  47 in total

Review 1.  Hypocretins in the control of sleep and wakefulness.

Authors:  Patricia Bonnavion; Luis de Lecea
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 2.  Hypocretin/orexin involvement in reward and reinforcement.

Authors:  Rodrigo A España
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

3.  Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons.

Authors:  Loris L Ferrari; Daniel Park; Lin Zhu; Matthew R Palmer; Rebecca Y Broadhurst; Elda Arrigoni
Journal:  J Neurosci       Date:  2018-01-08       Impact factor: 6.167

Review 4.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

5.  Narcolepsy and the T-cell receptor.

Authors:  Timothy J Vyse
Journal:  Nat Genet       Date:  2009-06       Impact factor: 38.330

Review 6.  Rewiring brain circuits to block cataplexy in murine models of narcolepsy.

Authors:  Meng Liu; Carlos Blanco-Centurion; Priyattam J Shiromani
Journal:  Curr Opin Neurobiol       Date:  2017-04-23       Impact factor: 6.627

7.  White and gray matter abnormalities in narcolepsy with cataplexy.

Authors:  Christoph Scherfler; Birgit Frauscher; Michael Schocke; Michael Nocker; Viola Gschliesser; Laura Ehrmann; Markus Niederreiter; Regina Esterhammer; Klaus Seppi; Elisabeth Brandauer; Werner Poewe; Birgit Högl
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

8.  Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.

Authors:  Christian R Baumann; Emmanuel Mignot; Gert Jan Lammers; Sebastiaan Overeem; Isabelle Arnulf; David Rye; Yves Dauvilliers; Makoto Honda; Judith A Owens; Giuseppe Plazzi; Thomas E Scammell
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

9.  Role of lateral hypothalamus in two aspects of attention in associative learning.

Authors:  Daniel S Wheeler; Sandy Wan; Alexandra Miller; Nicole Angeli; Bayan Adileh; Weidong Hu; Peter C Holland
Journal:  Eur J Neurosci       Date:  2014-04-21       Impact factor: 3.386

10.  Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats.

Authors:  Camille Planty; Corey P Mallett; Kevin Yim; Jorge C G Blanco; Marina Boukhvalova; Thomas March; Robbert van der Most; Eric Destexhe
Journal:  Hum Vaccin Immunother       Date:  2016-09-14       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.